Myasthenia gravis: clinical, immunological, and therapeutic advances
- 1 February 2005
- journal article
- review article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 111 (2) , 134-141
- https://doi.org/10.1111/j.1600-0404.2005.00374.x
Abstract
We give an update on clinical, immunological, and therapeutic advances in the field of myasthenia gravis, including a summary of suggested therapeutic recommendations.Keywords
This publication has 88 references indexed in Scilit:
- Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case reportThe Journal of Pediatrics, 2003
- Molecular Mimicry and AutoimmunityNew England Journal of Medicine, 1999
- The histomorphology of the thymus in late onset, non‐thymoma myasthenia gravisEuropean Journal of Neurology, 1998
- Antibody Effector Mechanisms in Myasthenia Gravis: The Complement HypothesisaAnnals of the New York Academy of Sciences, 1998
- Immuno-suppressive Peptides for a Human T Cell Clone Autoreactive to a Unique Acetylcholine Receptor α Subunit Peptide Presented by the Disease-Susceptible HLA-DQ6 in Infant-Onset Myasthenia GravisHuman Immunology, 1997
- Myasthenia GravisNew England Journal of Medicine, 1994
- Human monoclonal striational autoantibodies isolated from thymic B lymphocytes of patients with myasthenia gravis use VH and VL gene segments associated with the autoimmune repertoireEuropean Journal of Immunology, 1992
- Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodiesActa Neurologica Scandinavica, 1986
- Immunobiology of Myasthenia Gravis, Experimental Autoimmune Myasthenia Gravis, and Lambert-Eaton SyndromeAnnual Review of Immunology, 1985
- MYASTHENIA GRAVIS IMMUNOLOGICAL RELATIONSHIP BETWEEN STRIATED MUSCLE AND THYMUSThe Lancet, 1966